第37页 | 伯恩斯焦虑自助疗法-戴维·伯恩斯

同步阅读进度，多语言翻译，过滤屏幕蓝光，评论分享，更多完整功能，更好读书体验，试试阅读 ‧ 电子书库

参考文献

F. Scogin, D. Hamblin, and L. Beutler, “Bibliotherapy for Depressed Older Adults: A Self-Help Alternative,” The Gerontologist 27 (1987): 383–387.

F. Scogin, C. Jamison, and K. Gochneaut, “The Comparative Efficacy of Cognitive and Behavioral Bibliotherapy for Mildly and Moderately Depressed Older Adults,” Journal of Consulting and Clinical Psychology 57 (1989): 403–407.

F. Scogin, C. Jamison, and N. Davis, “A Two-Year Follow-up of the Effects of Bibliotherapy for Depressed Older Adults,” Journal of Consulting and Clinical Psychology 58 (1990): 665–667.

F. Scogin, C. Jamison, M. Floyd, and W. Chaplin, “Measuring Learning in Depression Treatment: A Cognitive Bibliotherapy Test,” Cognitive Therapy and Research 22 (1998): 475–482.

N. M. Smith, M. R. Floyd, C. Jamison, and F. Scogin, “Three-Year Follow-up of Bibliotherapy for Depression,” Journal of Consulting and Clinical Psychology 65(1997): 324–327.

R. J. DeRubeis, S. D. Hollon, J. D. Amsterdam, R. C. Shelton, P. R. Young, R. M. Salomon, J. P. O’Reardon, M. L. Lovett, M. M. Gladis, L. L. Brown, and R. Gallop, “Cognitive Therapy vs. Medications in the Treatment of Moderate to Severe Depression,” Archives of General Psychiatry 62 (2005): 409–416. Web abstract: http:// archpsych. ama-assn. org/cgi/content/abstract/62/4/409.

S. D. Hollon, R. J. DeRubeis, R. C. Shelton, J. D. Amsterdam, R. M. Salomon, J. P. O’Reardon, M. L. Lovett, P. R. Young, K. L. Haman, B. B. Freeman, and R. Gallop,“Prevention of Relapse Following Cognitive Therapy vs. Medications in Moderate to Severe Depression,” Archives of General Psychiatry 62 (2005): 417–422. Web abstract: http://archpsych. ama-assn. org/cgi/content/abstract/62/4/417.

As quoted in Medical News Today, July 8, 2005, “Cognitive Therapy as Good as Antidepressants, Effects Last Longer. ” Web link: http://medicalnewstoday. com/ medicalnews. php?newsid=22319#.

H. A. Westra and S. H. Stewart, “Cognitive Behavioral Therapy and Pharmacotherapy:Complementary or Contradictory Approaches to the Treatment of Anxiety?” Clinical Psychology Review 18, no. 3 (1998): 307–340.

H. A. Westra and S. H. Stewart, “Cognitive Behavioral Therapy and Pharmacotherapy: Complementary or Contradictory Approaches to the Treatment of Anxiety?”Clinical Psychology Review 18, no. 3 (1998): 307–340.

J. Mendels, J. L. Stinnett, D. D. Burns, and A. Frazer, “Amine Precursors and Depression,” Archives of General Psychiatry 32 (1975): 22–30.

Hypericum Depression Trial Study Group, “Effect of Hypericum perforatum(St. John’s Wort) in Major Depressive Disorder: A Randomized, Controlled Trial,”Journal of the American Medical Association 287 (2002): 1807–1814. Online summary: http://www. nih. gov/news/pr/apr2002/nccam-09. htm.

I. Kirsch and G. Sapirstein, “Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication,” Prevention and Treatment 1 (1998), article0002a. Online article: http://journals. apa. org/prevention/volume1/pre0010002a. html.

I. Kirsch, T. J. Moore, A. Scoboria, and S. S. Nicholls, “The Emperor’s New Drugs:An Analysis of Antidepressant Medication Data Submitted to the U. S. Food and Drug Administration,” Prevention and Treatment 5 (2002), article 23. Online article: http://journals. apa. org/prevention/volume5/pre0050023a. html.

S. H. Preskorn, “Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors: An Overview with Emphasis on Pharmacokinetics and Effects on Oxidative Drug Metabolism,” Clinical Pharmacokinetics 32, suppl. 1 (1997): 1–21.

I. Kirsch and G. Sapirstein, “Listening to Prozac but Hearing Placebo: A MetaAnalysis of Antidepressant Medication,” Prevention and Treatment 1 (1998), article 0002a. Online article: http://journals. apa. org/prevention/volume1/pre0010002a. html.

I. Kirsch, T. J. Moore, A. Scoboria, and S. S. Nicholls, “The Emperor’s New Drugs: An Analysis of Antidepressant Medication Data Submitted to the U. S. Food and Drug Administration,” Prevention and Treatment 5 (2002), article 23. Online article: http://journals. apa. org/prevention/volume5/pre0050023a. html.

D. O. Antonuccio, W. G. Danton, and G. Y. DeNelsky, “Psychotherapy versus Medication for Depression: Challenging the Conventional Wisdom with Data,”Professional Psychology: Research and Practice 26 (1995): 574–585.

D. O. Antonuccio, W. G. Danton, G. Y. DeNelsky, R. Greenberg, and J. S. Gordon,“Raising Questions about Antidepressants,” Psychotherapy and Psychosomatics 68(1999): 3–14.

D. O. Antonuccio, D. Burns, and W. G. Danton, “Antidepressants: A Triumph of Marketing over Science?” Prevention and Treatment 5 (2002), article 25. Online article: http://journals. apa. org/prevention/volume5/toc-jul15-02. htm.

E. J. Garland, “Facing the Evidence: Antidepressant Treatment in Children and Adolescents,” Canadian Medical Association Journal 170 (2004): 489–491.

N. Jureidini, C. J. Doecke, P. R. Mansfield, M. M. Haby, D. B. Menkes, and A. L. Tonkin, “Efficacy and Safety of Antidepressants in Children and Adolescents,”British Medical Journal 328 (2004): 879–883.

C. J. Whittington, T. Kendall, P. Fonagy, D. Cottrell, A. Colgrove, and E. Boddington, “Selective Serotonin Reuptake Inhibitors in Childhood Depression: Systematic Review of Published versus Unpublished Data,” Lancet 363 (2004): 1341–1345.

D. Healy, “Lines of Evidence on the Risk of Suicide with Selective Serotonin Reuptake Inhibitors,” Psychotherapy and Psychosomatics 72 (2003): 71–79.

H. A. Westra and S. H. Stewart, “Cognitive Behavioral Therapy and Pharmacotherapy: Complementary or Contradictory Approaches to the Treatment of Anxiety?” Clinical Psychology Review 18, no. 3 (1998): 307–340.